ข่าวประชาสัมพันธ์ Press Releases ข่าวย้อนหลัง หัวข้อข่าว บลอก

วันพุธที่ ๑๘ มกราคม พ.ศ. ๒๕๖๐ ๑๒:๔๙ น.

Food and Healthcare Press Releases

Merck Opens Production Facility Exclusively for Meglumine in Spain Heathcare—๑๘ ม.ค. ๖๐

Merck , a leading science and technology company, today announced the opening of a facility in Mollet des Valles, Spain dedicated to the manufacture of meglumine, an FDA-approved excipient for pharmaceuticals and a component of medical imaging contrast

Genea and Merck Open Fertility Centre of Excellence Heathcare—๑๗ ม.ค. ๖๐

Australian fertility group Genea and German science and technology company Merck have today opened The Centre of Excellence for Fertility in Bangkok. The Centre of Excellence for Fertility has been developed with the goal of creating a global benchmark

OrbusNeich Expands Portfolio with a Next Generation Coronary Scoring Heathcare—๑๑ ม.ค. ๖๐

Launch of Scoreflex(TM) NC responds to cardiologists' need for a non-compliant scoring balloon in more resistant lesions OrbusNeich, a global company specializing in the provision of life-changing vascular solutions, has launched the Scoreflex NC, a

Merck Expands End-to-End Biodevelopment Centers in North America, China and Heathcare—๑๑ ม.ค. ๖๐

- Biodevelopment centers in Boston, Mass. and Shanghai, China feature full suite of Merck technologies and services - New process development centers and full single-use GMP facility in France to accelerate development of biologics Merck , a leading

Sun Pharma Announces Positive Topline Results of Confirmatory Phase-3 Clinical Trial for Heathcare—๕ ม.ค. ๖๐

Sun Pharma announced successful Phase 3 confirmatory clinical trial results for Seciera(TM) (cyclosporine A, 0.09% ophthalmic solution), for the treatment of dry eye disease. Seciera(TM) is a patented, novel, proprietary nanomicellar formulation of

Get yourself ready for the ultimate beauty trend of 2017 with Romrawin Heathcare—๕ ม.ค. ๖๐

New Year is right around the corner! Ring in 2017 with confidence and discover the upcoming beauty trends from the insiders with Romrawin, premium beauty center and Thailand's leading aesthetic clinic, who will share with you what's hot and what's

Merck Acquires BioControl to Strengthen Position in Food Safety Testing Heathcare—๕ ม.ค. ๖๐

- Enables Merck to offer its customers complete workflow solutions for food pathogen testing Merck , a leading life science and technology company, today announced it has acquired BioControl Systems Inc., a global leader in food safety testing. The

The First Dengue Vaccine in Thailand is Available at Samitivej Heathcare—๒๘ ธ.ค. ๕๙

On December 20th, 2016, Samitivej Hospital held a press conference on the evolution of dengue prevention in Thailand which has led to the introduction of the first vaccine against four strains of the dengue virus, reducing its severity and allowing a

BioNet Received Thai FDA Approval of the Worlds Only Available Recombinant Monovalent Acellular Heathcare—๒๓ ธ.ค. ๕๙

BioNet's vaccine is the first recombinant monovalent Pertussis vaccine in the world to receive a MAA for booster indication in adolescents and adults BioNet-Asia announced today that its first recombinant acellular Pertussis booster vaccine containing a

Lancet Infectious Diseases Publishes Independent Double-Blind Study Validating MeMed#s Heathcare—๒๒ ธ.ค. ๕๙

Use of ImmunoXpert has the potential to improve patient management and reduce drug resistance due to antibiotic overuse ImmunoXpert significantly outperformed routine tests MeMed Ltd. announced today Lancet Infectious Diseases' publication of the

Photo Release: Bumrungrad receives 2016 AMCHAM CSR Excellence Award Heathcare—๒๑ ธ.ค. ๕๙

Mr. Ronald Lavater (5th from right), Bumrungrad's Corporate CEO, recently led the project's physicians and nursing team to receive the 4th award from H.E. Glyn Townsend Davies, the U.S. Ambassador to Thailand (5th from left). The award was granted by the

AGC Asahi Glass Signs Agreement to Acquire CMC Biologics Heathcare—๒๐ ธ.ค. ๕๙

BOTHELL, Washington and COPENHAGEN, Denmark and BERKELEY, California and TOKYO--20 Dec--PRNewswire/InfoQuest CMC Biologics to continue to provide CDMO services to the biopharma marketplace CMC Biologics, a global leader in clinical and commercial

AGC Signs Agreement for Acquisition of Leading Biopharmaceutical CDMO, CMC Heathcare—๒๐ ธ.ค. ๕๙

AGC Asahi Glass ("AGC"), a world-leading manufacturer of glass, chemicals and high-tech materials, announced on December 20 that it has entered into an agreement to acquire 100% of the shares in CMC Biologics ("CMC"), a world-leading biologics active

OGT Expands Cytocell Sarcoma FISH Probe Range Heathcare—๑๖ ธ.ค. ๕๙

Oxford Gene Technology[ http://www.ogt.com ] (OGT), The Molecular Genetics Company, has expanded its range of Cytocell Aquarius(R) fluorescence in situ hybridisation (FISH) probes for pathology. OGT has introduced three new probes: FUS Breakapart and

USC Leonard Davis School ประกาศแต่งตั้งผู้ดำรงตำแหน่ง Kevin Xu Chair in Heathcare—๑๕ ธ.ค. ๕๙

เมื่อวันจันทร์ที่ 12 ธันวาคมที่ผ่านมา ณ ห้องบอลรูม USC Town and Gown คุณพินชาส โคเฮน คณบดีประจำ USC Leonard Davis School of Gerontology ได้ประกาศสถาปนาตำแหน่ง Kevin Xu Chair in Gerontology รวมถึงประกาศคุณงามความดีของ Rongxiang Xu Regenerative Life

Kevin Xu Chair in Gerontology is installed at USC Leonard Davis School Heathcare—๑๕ ธ.ค. ๕๙

At USC Town and Gown on Monday, December 12, USC Leonard Davis School of Gerontology Dean Pinchas Cohen announced the installation of Kevin Xu Chair in Gerontology and the dedication of Rongxiang Xu Regenerative Life Science Lab, made possible with

International Group Supports Global Efforts To End Dental Mercury Usage Heathcare—๑๕ ธ.ค. ๕๙

Last week, three EU institutions (the European Parliament, the European Commission and the Council of the European Union) reached a provisional agreement to ban dental amalgam fillings for children under 15 and pregnant and breastfeeding women as of July

Tillotts Pharma AG#s Parent Company Zeria Pharmaceutical Launches Zentacort(R) 3mg Capsules in Heathcare—๑๕ ธ.ค. ๕๙

Zeria Pharmaceutical Co., Ltd launched Zentacort(R) 3mg capsules (generic name: Budesonide) in Japan on November 29, 2016. Zentacort(R) is sold as Entocort(TM) in more than 40 countries and recommended as first line therapy for treatment in Crohn's

Lilly Announces Detailed Results of Solanezumab Phase 3 EXPEDITION3 Study at the Clinical Trials on Heathcare—๙ ธ.ค. ๕๙

Eli Lilly and Company (NYSE:LLY) today presented detailed results of its phase 3 EXPEDITION3 trial at the 9th Clinical Trials on Alzheimer's Disease (CTAD) meeting. As previously disclosed, solanezumab did not meet the primary endpoint in the EXPEDITION3

OGT Releases Targeted NGS Panel to Study SNV and CNV in Familial Hypercholesterolemia Heathcare—๙ ธ.ค. ๕๙

Oxford Gene Technology (OGT), The Molecular Genetics Company, has expanded its customisable SureSeq(TM) NGS panel range with the launch of the SureSeq myPanel(TM) NGS Custom FH Panel - allowing fast and cost-effective study of variants in familial

Mederi#s Stretta Therapy for GERD approved in China Heathcare—๙ ธ.ค. ๕๙

Clinically proven and cost effective solution for gastroesophageal reflux disease recently launched in China. Mederi Therapeutics Inc. has announced regulatory approval by CFDA and product launch in China for Stretta Therapy, a non-surgical treatment

Nordion and General Atomics welcome US National Nuclear Security Administration Phase II funding Heathcare—๘ ธ.ค. ๕๙

Nordion, a standalone business of Sterigenics International, in partnership with General Atomics (GA), welcome today's award by the United States Department of Energy's (DOE) National Nuclear Security Administration (NNSA) of the Phase II cooperative

Merck#s Consumer Health Business Drives Consumer-Centric, Purposeful Heathcare—๖ ธ.ค. ๕๙

- Innovation and digital presence identified as main drivers of successful engagement with consumers and healthcare professionals Merck, a leading science and technology company, has developed a novel approach to product co-creation for its Consumer

NovoSeven(R) Resolved 96.5% of Bleeds When Initiated Within One Hour After Bleed Onset in People Heathcare—๖ ธ.ค. ๕๙

Novo Nordisk today announced that NovoSeven(R) (rFVIIa), a portable room temperature stable recombinant activated factor VIIa, resolved 96.5% of bleeds when initiated within one hour after onset of bleeding, demonstrating efficacy of early treatment in